跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 174 条关于
“DPP9”
全部
174
临床试验
152
药物
10
机构
1
资讯
11
2个月前
Hidden lung-specific DPP9 protein variant linked to severe COVID-19 and lung fibrosis
6个月前
Melodia Therapeutics Secures Key U.S. Patent for Novel DPP1 Inhibitor MLD-151
去年
DPP4 Inhibitor Shows Promise in Rejuvenating Lung Stem Cells for Idiopathic Pulmonary Fibrosis
上个月
Expedition Therapeutics Raises $115M Series B as DPP1 Inhibitor EXPD-101 Enters Phase 2 COPD Trial
11个月前
Expedition Therapeutics Secures $165 Million Series A to Advance First-in-Class DPP1 Inhibitor for COPD
上个月
Expedition Therapeutics Raises $115M Series B to Advance First Global Phase 2 Trial of DPP1 Inhibitor in COPD
去年
Fosun Pharma Secures $645 Million Global Licensing Deal for Novel DPP-1 Inhibitor XH-S004
去年
Expedition Therapeutics Secures $645M Deal for Chinese DPP-1 Inhibitor in Growing Cross-Border Biotech Trend
去年
Landmark DPP and DPPOS Studies Show Long-Term Benefits of Lifestyle Changes and Metformin in Diabetes Prevention
去年
GLP-1 Receptor Agonists Show Lower Risk for MACE and VTE in Lupus and Type 2 Diabetes Patients Compared to DPP4 Inhibitors
第 1 页,共 2 页
上一页
下一页